Stay updated with breaking news from Nasdaq Ppbt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Purple Biotech (NASDAQ:PPBT – Free Report) in a research note published on Friday morning, Benzinga reports. They currently have a $10.00 price objective on the stock. Purple Biotech Price Performance Shares of Purple Biotech stock opened at $0.51 on Friday. The firm has a market cap […]
Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 418,100 shares, a decrease of 7.7% from the January 15th total of 452,800 shares. Based on an average trading volume of 80,300 shares, […]
Purple Biotech Ltd. (NASDAQ:PPBT – Get Free Report) shares traded up 3.2% during trading on Wednesday . The stock traded as high as $0.82 and last traded at $0.80. 84,212 shares changed hands during mid-day trading, a decline of 9% from the average session volume of 92,756 shares. The stock had previously closed at $0.77. […]
Initial Activity in Head and Neck Cancer Demonstrated in NT219 Phase 1/2 Dose Escalation Study Patients’ Enrollment in the Phase 2 Randomized CM24...
REHOVOT, Israel, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company...